SCHEMBL23078591

SCHEMBL23078591

c1ccc(N(c2ccccc2)c2ccc(-c3ccccc3-n3c4ccccc4c4ccccc43)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.44
ATM Q13315 3/20 0.44
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 5/20 0.42
MAPT P10636 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
MGLL Q99685 1/20 0.34
APP P05067 1/20 0.34
MAPK14 Q16539 1/20 0.33
HTR1A P08908 1/20 0.33
HTR2A P28223 1/20 0.33
HTR7 P34969 1/20 0.33
HTR5A P47898 1/20 0.33
HTR6 P50406 1/20 0.33
HDAC4 P56524 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24080779 0.98 L3MBTL1 (0.43) L3MBTL1ATMKDM4EALDH1A1MAPT
SCHEMBL24902254 0.98 L3MBTL1 (0.43) L3MBTL1ATMKDM4EALDH1A1MAPT
SCHEMBL24080777 0.98 L3MBTL1 (0.43) L3MBTL1ATMKDM4EALDH1A1MAPT
SCHEMBL23154504 0.97 KDM4E (0.42) L3MBTL1ATMKDM4EALDH1A1MAPT
SCHEMBL20009730 0.97 KDM4E (0.42) L3MBTL1ATMKDM4EALDH1A1MAPT
SCHEMBL24946812 0.97 KDM4E (0.42) L3MBTL1ATMKDM4EALDH1A1MAPT
SCHEMBL24902742 0.97 KDM4E (0.42) L3MBTL1ATMKDM4EALDH1A1MAPT
SCHEMBL24119027 0.97 KDM4E (0.42) L3MBTL1ATMKDM4EALDH1A1MAPT
SCHEMBL24903075 0.95 KDM4E (0.41) L3MBTL1ATMKDM4EALDH1A1MAPT
SCHEMBL23154506 0.95 KDM4E (0.43) L3MBTL1ATMKDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240018104-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2024-01-18 US disclosed
WO-2023002447-A1 ORGANIC LIGHT-EMITTING DEVICE 주식회사 엘지화학 2023-01-26 WO disclosed
WO-2023003403-A1 ORGANIC LIGHT-EMITTING DEVICE 주식회사 엘지화학 2023-01-26 WO disclosed
WO-2021045347-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME 주식회사 엘지화학 2021-03-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240018104-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF NFE2L2, ESR1, OR51E2 L3MBTL1 587/4885ATM 2358/4885KDM4E 436/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.